ZimmerBiomet Holdings Inc. confirmed on a recent earnings call that the company’s US FDA quality systems compliance challenges aren’t over quite yet.
The firm received additional observations after FDA’s most recent inspection of its Warsaw North Campus facility in Warsaw, Ind., President and CEO Bryan Hanson said during a July 27 call....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?